Omega-3 Fatty Acids and Cardiovascular Disease

EHC Program Updates: New AHRQ Publications Summarize Evidence on Omega-3 Fatty Acids and Cardiovascular Disease, and Insomnia Disorder

The Effective Health Care Program has posted the following new AHRQ publications on its Web site.

Omega-3 Fatty Acids and Cardiovascular Disease

These new AHRQ publications can help clinicians and patients learn about the effects of omega-3 fatty acids on heart disease.  Omega-3 Fatty Acids and Cardiovascular Disease: Current State of the Evidence suggests that in healthy people, dietary intake of fish oil may help lower the risk of  CVD death and stroke.  In people already diagnosed or at increased risk for heart disease, evidence showed fish oil supplements do not lower the risk of longer term heart problems, such as heart attack and heart failure, and death.  The companion publication for patients Omega-3 Fatty Acids and Cardiovascular Disease – A Review of the Research for Adults may help consumers talk about the benefits and risks of omega-3 fatty acids.

Insomnia Disorder

These new AHRQ publications can help clinicians and patients effectively manage insomnia disorder, defined as a long-term condition in which a person has trouble sleeping at least three nights each week for at least three months. The clinical guide Management of Insomnia Disorder in Adults: Current State of the Evidence found evidence that cognitive behavioral therapy for insomnia can be effective and safe as a treatment. Some short-term studies found that medications were also effective for treating insomnia, but they have potential side effects. Also available is AHRQ’s guide for patients about managing insomnia disorder that will help inform treatment option discussions between clinicians, patients and caregivers.

Effective Health Care Program
https://www.effectivehealthcare.ahrq.gov